BofA’s Raedler Says Defensives Ready to Roar if AI Trade Falters

BofA strategist Sebastian Raedler warned that investors should rotate into defensive sectors if the AI trade starts to unravel, arguing AI may never become a high-margin business capable of justifying heavy capital expenditure. He highlighted consumer staples and pharma as “left-behind” areas with more reliable underlying business logic. The piece is a positioning call rather than a hard catalyst, so the market impact is likely limited.

Analysis

The key market implication is not that defensives become absolute longs, but that AI leadership is increasingly crowded and duration-sensitive. If the marginal buyer stops paying for multiple expansion on distant cash flows, the first-order hit lands in high-beta AI enablers, but the second-order effect is a rotation into sectors where earnings visibility and dividend support can attract incremental capital with lower earnings risk. That rotation can be sharp because many defensives have been structurally under-owned; even a modest de-risking from growth could force reallocations into staples and pharma faster than fundamentals alone would justify.

The more interesting setup is relative performance over the next 1-3 months: if AI capex concerns broaden into a narrative that returns on invested capital are being deferred, hardware, semis, and infrastructure names become the weakest link, while healthcare and staples benefit from lower earnings dispersion and cleaner guidance. Within defensives, pharma may outperform staples if investors want cash-flow resilience without the same input-cost and private-label pressure that can cap staples multiples. Consumer demand weakness is a hidden tailwind here: any slowdown in discretionary spending makes defensive revenue more defensive, but it also caps upside because volume growth remains limited.

The contrarian risk is that the “AI bubble” unwind may be overstated in the near term. Capex can keep rising even if ROI is unclear, because hyperscalers are incentivized to preserve strategic positioning and competitors cannot easily sit out; that delays the inflection point and keeps the trade painful for premature shorts. If AI monetization milestones arrive or enterprise demand inflects, defensives likely underperform again because the market will re-rate growth before fundamentals in cyclicals noticeably deteriorate.

BAC-specific takeaway: the note is more about positioning than a company-specific negative. A cautious strategist calling for defensives can itself be a sentiment signal—if the market has already trimmed growth exposure, the tradeable move may be smaller than the headline suggests. The best expression is relative value, not outright market timing.

Key Decisions for Investors

• Rotate tactically into XLP and XLV over the next 2-6 weeks, but prefer XLV if you want a cleaner hedge against AI factor de-rating; expected return is lower upside than growth, but better drawdown control if the AI trade unwinds.
• Short a basket of AI infrastructure beneficiaries against longs in defensives: e.g., short SMH or SOXX / long XLP in a 1:1 dollar pair; target a 5-8% relative move over 1-3 months if AI multiple compression continues.
• Use options to express the view with defined risk: buy 3-6 month puts on high-multiple AI winners or semis and finance partially by selling calls on XLP/XLV; this favors a fast factor rotation without needing a full market selloff.
• If you want to fade the warning, wait for a 5-10% pullback in AI-related names before re-entering longs; the market may need one more evidence point on earnings or capex before repricing the theme, which improves risk/reward on dip buys.
• Avoid chasing defensives after a two-day spike; if the rotation is real, the best entry is on a failed rebound in growth rather than immediately after the first headline-driven move.